Mercury poisoning;Intoxication par le mercure

Revue de Medecine Interne

Volumn 32, Issue 7, 2011, Pages 416-424

  Bensefa Colas, L ^a   Andujar, P ^b,c,d   Descatha, A ^e,f  

^a AP HP ^*  (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e RAYMOND POINCARÉ HOSPITAL   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Mercury; Methylmercury; Toxicity

Indexed keywords

CHELATING AGENT; METHYLMERCURY;

BRAIN DISEASE; ENVIRONMENTAL EXPOSURE; GLOMERULONEPHRITIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LUNG DISEASE; MERCURIALISM; NEUROLOGIC DISEASE; SHORT SURVEY; TOXIC INHALATION;

CHELATION THERAPY; ENVIRONMENTAL EXPOSURE; GASTRIC LAVAGE; HUMANS; MERCURY; MERCURY POISONING;

EID: 79959340804     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.08.024     Document Type: Short Survey

References (66)

1. United Nation Environment Programme (UNEP) - Chemicals. Global Mercury Assessment. Geneva, 2002. 266 pages.
2. Lauwerys R.R., Haufroid V., Hoet P., Lison D. Mercure. Toxicologie industrielle et intoxication professionnelle 2007, 309-363. Elsevier Masson, Paris.
3. Clarkson T.W. The three modern faces of mercury. Environ Health Perspect 2002, 110(Suppl 1):11-23.
4. Clarkson T., Cox C., Davidson P.W., Myers G.J. Mercury in fish. Science 1998, 279:459-461.
5. World Health Organization. International Programme on chemical Safety: Methylmercury. Vol. 101. Geneva, 1990.
6. Tsubaki T., Sato T. Mercury poisoning in Niigata. Kango Gijutsu 1966, 12:47-56.
7. Bakir F., Damluji S.F., Amin-Zaki L., Murtadha M., Khalidi A., al-Rawi N.Y., et al. Methylmercury poisoning in Iraq. Science 1973, 181:230-241.
8. Jalili M.A., Abbasi A.H. Poisoning by ethyl mercury toluene sulphonanilide. Br J Ind Med 1961, 18:303-308.
9. Cherian M.G., Hursh J.B., Clarkson T.W., Allen J. Radioactive mercury distribution in biological fluids and excretion in human subjects after inhalation of mercury vapor. Arch Environ Health 1978, 33:109-114.
10. World Health Organization. Elementary mercury and inorganic mercury compounds: human health aspects. Concise International Chemical Assessment Document 50. Geneva, 2003.
11. Wright N., Yeoman W.B., Carter G.F. Massive oral ingestion of elemental mercury without poisoning. Lancet 1980, 1:206.
12. Garnier R. Mercure. Toxicologie clinique 2000, 614-623. Flammarion Médecine Science, Paris. C. Bismuth, A. et (Eds.).
13. Hursh J.B., Clarkson T.W., Miles E.F., Goldsmith L.A. Percutaneous absorption of mercury vapor by man. Arch Environ Health 1989, 44:120-127.
14. Barr R.D., Woodger B.A., Rees P.H. Levels of mercury in urine correlated with the use of skin lightening creams. Am J Clin Pathol 1973, 59:36-40.
15. De Bont B., Lauwerys R., Govaerts H., Moulin D. Yellow mercuric oxide ointment and mercury intoxication. Eur J Pediatr 1986, 145:217-218.
16. Al-Saleh I., Shinwari N. Urinary mercury levels in females: influence of skin-lightening creams and dental amalgam fillings. Biometals 1997, 10:315-323.
17. Deleu D., Hanssens Y., al-Salmy H.S., Hastie I. Peripheral polyneuropathy due to chronic use of topical ammoniated mercury. J Toxicol Clin Toxicol 1998, 36:233-237.
18. Olumide Y.M., Akinkugbe A.O., Altraide D., Mohammed T., Ahamefule N., Ayanlowo S., et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol 2008, 47:344-353.
19. Sundberg J., Ersson B., Lönnerdal B., Oskarsson A. Protein binding of mercury in milk and plasma from mice and man-a comparison between methylmercury and inorganic mercury. Toxicology 1999, 137:169-184.
20. Kerper L.E., Mokrzan E.M., Clarkson T.W., Ballatori N. Methylmercury efflux from brain capillary endothelial cells is modulated by intracellular glutathione but not ATP. Toxicol Appl Pharmacol 1996, 141:526-531.
21. Testud F. Mercure. Pathologie toxique professionnelle et environnementale 2005, 239-251. Eska, Paris.
22. Kang-Yum E., Oransky S.H. Chinese patent medicine as a potential source of mercury poisoning. Vet Hum Toxicol 1992, 34:235-238.
23. Murphy M.J., Culliford E.J., Parsons V. A case of poisoning with mercuric chloride. Resuscitation 1979, 7:35-44.
24. Lilis R., Miller A., Lerman Y. Acute mercury poisoning with severe chronic pulmonary manifestations. Chest 1985, 88:306-309.
25. Matthes F.T., Kirschner R., Yom M.D., Brennan J.C. Acute poisoning associated with inhalation of mercury vapor; report of four cases. Pediatrics 1958, 22:675-688.
26. Milne J., Christophers A., de Silva P. Acute mercurial pneumonitis. Br J Ind Med 1970, 27:334-338.
27. Taueg C., Sanfilippo D.J., Rowens B., Szejda J., Hesse J.L. Acute and chronic poisoning from residential exposures to elemental mercury-Michigan, 1989-1990. J Toxicol Clin Toxicol 1992, 30:63-67.
28. Kanerva L., Rantanen T., Aalto-Korte K., Estlander T., Hannuksela M., Harvima R.J., et al. A multicenter study of patch test reactions with dental screening series. Am J Contact Dermat 2001, 12:83-87.
29. Nakayama H., Niki F., Shono M., Hada S. Mercury exanthem. Contact Dermatitis 1983, 9:411-417.
30. World Health Organization. International Programme on chemical Safety: Inorganic mercury. Vol. 118. Geneva, 1991.
31. Bidstrup P.L., Bonnell J.A., Harvey D.G., Locket S. Chronic mercury poisoning in men repairing direct-current meters. Lancet 1951, 2:856-861.
32. Chapman L.J., Sauter S.L., Henning R.A., Dodson V.N., Reddan W.G., Matthews C.G. Differences in frequency of finger tremor in otherwise asymptomatic mercury workers. Br J Ind Med 1990, 47:838-843.
33. Fawer R.F., de Ribaupierre Y., Guillemin M.P., Berode M., Lob M. Measurement of hand tremor induced by industrial exposure to metallic mercury. Br J Ind Med 1983, 40:204-208.
34. Piikivi L., Hänninen H. Subjective symptoms and psychological performance of chlorine-alkali workers. Scand J Work Environ Health 1989, 15:69-74.
35. Hua J., Pelletier L., Berlin M., Druet P. Autoimmune glomerulonephritis induced by mercury vapour exposure in the Brown Norway rat. Toxicology 1993, 79:119-129.
36. Makker S.P., Aikawa M. Mesangial glomerulonephropathy with deposition of IgG, IgM, and C3 induced by mercuric chloride: a new model. Lab Invest 1979, 41:45-50.
37. Langworth S., Elinder C.G., Sundquist K.G., Vesterberg O. Renal and immunological effects of occupational exposure to inorganic mercury. Br J Ind Med 1992, 49:394-401.
38. Fuortes L.J., Weismann D.N., Graeff M.L., Bale J.F., Tannous R., Peters C. Immune thrombocytopenia and elemental mercury poisoning. J Toxicol Clin Toxicol 1995, 33:449-455.
39. Cavalleri A., Gobba F. Reversible color vision loss in occupational exposure to metallic mercury. Environ Res 1998, 77:173-177.
40. Urban P., Gobba F., Nerudová J., Lukás E., Cábelková Z., Cikrt M. Color discrimination impairment in workers exposed to mercury vapor. Neurotoxicology 2003, 24:711-716.
41. Agence française de sécurité sanitaire des produits de santé (Afssaps). Le mercure des amalgames dentaires: actualisation des connaissances. Mise en place d'un réseau d'évaluation pluridisciplinaire. Recommandations. Paris, France, 2005: 103 pages.
42. Camisa C., Taylor J.S., Bernat J.R., Helm T.N. Contact hypersensitivity to mercury in amalgam restorations may mimic oral lichen planus. Cutis 1999, 63:189-192.
43. Bellinger D.C., Trachtenberg F., Barregard L., Tavares M., Cernichiari E., Daniel D., et al. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA 2006, 295:1775-1783.
44. DeRouen T.A., Martin M.D., Leroux B.G., Townes B.D., Woods J.S., Leitão J., et al. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA 2006, 295:1784-1792.
45. Thompson C.M., Markesbery W.R., Ehmann W.D., Mao Y.X., Vance D.E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 1988, 9:1-7.
46. IARC. IARC Monographs on the evaluation of carcinogenic risks to humans. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Lyon, France 1993 ;58: 444 pages.
47. Hook O., Lundgren K.D., Swensson A. On alkyl mercury poisoning; with a description of two cases. Acta Med Scand 1954, 150:131-137.
48. Weiss B., Clarkson T.W., Simon W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 2002, 110(Suppl. 5):851-854.
49. Cernichiari E., Brewer R., Myers G.J., Marsh D.O., Lapham L.W., Cox C., et al. Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology 1995, 16:705-710.
50. Harada M. Intrauterine poisoning clinical and epidemiological studies and significance of the problem. Bull Inst Constitutional Med (Kumamoto University) 1976, 25(Suppl.):1-59.
51. Cox C., Clarkson T.W., Marsh D.O., Amin-Zaki L., Tikriti S., Myers G.G. Dose-response analysis of infants prenatally exposed to methyl mercury: an application of a single compartment model to single-strand hair analysis. Environ Res 1989, 49:318-332.
52. Cox C., Marsh D., Myers G., Clarkson T. Analysis of data on delayed development from the 1971-72 outbreak of methylmercury poisoning in Iraq: assessment of influential points. Neurotoxicology 1995, 16:727-730.
53. McKeown-Eyssen G.E., Ruedy J., Neims A. Methyl mercury exposure in northern Quebec. II. Neurologic findings in children. Am J Epidemiol 1983, 118:470-479.
54. Marsh D.O., Turner M.D., Smith J.C., Allen P., Richdale N. Fetal methylmercury study in a Peruvian fish-eating population. Neurotoxicology 1995, 16:717-726.
55. Myers G.J., Davidson P.W., Cox C., Shamlaye C., Cernichiari E., Clarkson T.W. Twenty-seven years studying the human neurotoxicity of methylmercury exposure. Environ Res 2000, 83:275-285.
56. Myers G.J., Davidson P.W., Cox C., Shamlaye C.F., Palumbo D., Cernichiari E., et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003, 361:1686-1692.
57. Grandjean P., Weihe P., White R.F. Milestone development in infants exposed to methylmercury from human milk. Neurotoxicology 1995, 16:27-33.
58. Grandjean P., Weihe P., White R.F., Debes F., Araki S., Yokoyama K., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997, 19:417-428.
59. Grandjean P., Weihe P., White R.F., Debes F. Cognitive performance of children prenatally exposed to " safe" levels of methylmercury. Environ Res 1998, 77:165-172.
60. Cordier S., Garel M., Mandereau L., Morcel H., Doineau P., Gosme-Seguret S., et al. Neurodevelopmental investigations among methylmercury-exposed children in French Guiana. Environ Res 2002, 89:1-11.
61. Blanusa M., Varnai V.M., Piasek M., Kostial K. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem 2005, 12:2771-2794.
62. Guzzi G., La Porta C.A. Molecular mechanisms triggered by mercury. Toxicology 2008, 244:1-12.
63. Ball L.K., Ball R., Pratt R.D. An assessment of thimerosal use in childhood vaccines. Pediatrics 2001, 107:1147-1154.
64. Parker S.K., Schwartz B., Todd J., Pickering L.K. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004, 114:793-804. [Erratum in: Pediatrics 2005;115:200].
65. Thompson W.W., Price C., Goodson B., Shay D.K., Benson P., Hinrichsen V.L., et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007, 357:1281-1292.
66. Tozzi A.E., Bisiacchi P., Tarantino V., De Mei B., D'Elia L., Chiarotti F., et al. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines. Pediatrics 2009, 123:475-482.